Original language | English (US) |
---|---|
Pages (from-to) | E008477 |
Journal | Circulation: Heart Failure |
Volume | 14 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1 2021 |
Keywords
- COVID-19
- data collection
- intensive care units
- registries
- shock, cardiogenic
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Circulation: Heart Failure, Vol. 14, No. 12, 01.12.2021, p. E008477.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Epidemiology of Cardiogenic Shock in Hospitalized Adults with COVID-19
T2 - A Report from the American Heart Association COVID-19 Cardiovascular Disease Registry
AU - Varshney, Anubodh S.
AU - Omar, Wally A.
AU - Goodrich, Erica L.
AU - Bhatt, Ankeet S.
AU - Wolley, Ann E.
AU - Gong, Jingyi
AU - Senman, Balimkiz C.
AU - Silva, Danuzia
AU - Levangie, Michael W.
AU - Berg, David D.
AU - Yeh, Robert W.
AU - de Lemos, James A.
AU - Morrow, David A.
AU - Kazi, Dhruv S.
AU - Bohula, Erin A.
N1 - Funding Information: Dr Varshney is on the Advisory Board for Broadview Ventures and is supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL007604 and the Daniel Pierce Family Fellowship in Advanced Heart Disease. Dr Bhatt reports speaking fees from Sanofi Pasteur and is supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL007604. Dr Berg is supported by Harvard Catalyst KL2/Catalyst Medical Research Investigator Training (National Institutes of Health/National Center for Advancing Translational Sciences UL 1TR002541) and has received consulting fees from AstraZeneca. Dr Yeh is a consultant for Abbott Vascular, AstraZeneca, Boston Scientific, Edwards Life Sciences, Medtronic, Shockwave Medical, and Zoll Medical and receives research funding from AstraZeneca, BD Bard, Boston Scientific, Cook Medical, Medtronic, and Philips. Dr de Lemos reports grant support from Roche Diagnostics and Abbott Diagnostics and consulting fees from Ortho Clinical Diagnostics, Siemen’s Health Care Diagnostics, Quidel, Eli Lilly, and Novo Nordisk. Dr Morrow has received consulting fees from Bayer Pharma, InCarda, Merck, Novartis, and Roche Diagnostics. Dr Bohula has received consulting fees from Novo Nordisk, Amgen, Medscape, Servier, and Kowa. Drs Morrow, Bohula, and Berg, M.W. Levangie, and E.L. Goodrich are members of the TIMI study group, which has received institutional research grant support through the Brigham and Women’s Hospital from Abbott Laboratories, Amgen, Anthos Therapeutics, Arca Biopharma, AstraZeneca, Bayer HealthCare Pharmaceuticals Inc, BRAHMS, Daiichi-Sankyo, Eisai, GlaxoSmithKline, Intarcia, Janssen, Merck, Novartis, Pfizer, Poxel, Quark Pharmaceuticals, Regeneron, Roche, Siemens, Takeda, The Medicines Company, and Zora Biosciences. The other authors report no conflicts. Funding Information: The American Heart Association (AHA) suite of registries is funded by multiple industry sponsors. AHA’s COVID-19 Cardiovascular Disease Registry is partially supported by the Gordon and Betty Moore Foundation.
PY - 2021/12/1
Y1 - 2021/12/1
KW - COVID-19
KW - data collection
KW - intensive care units
KW - registries
KW - shock, cardiogenic
UR - http://www.scopus.com/inward/record.url?scp=85122128753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122128753&partnerID=8YFLogxK
U2 - 10.1161/CIRCHEARTFAILURE.121.008477
DO - 10.1161/CIRCHEARTFAILURE.121.008477
M3 - Letter
C2 - 34789004
AN - SCOPUS:85122128753
SN - 1941-3289
VL - 14
SP - E008477
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
IS - 12
ER -